The CRISP3 (Cysteine Rich Secretory Protein 3) gene encodes a secreted protein involved in reproductive biology, immune response, and is associated with certain diseases, notably prostate cancer[3][4][6][8].

Key Concepts and Definitions

• Gene Family: CRISP3 belongs to the cysteine-rich secretory protein (CRISP) family, part of the CAP (CRISP, Antigen 5, and Pathogenesis-related 1) superfamily[3][8].
• Protein Structure: The protein has an N-terminal CAP domain, a hinge region, and a C-terminal ion channel regulator domain. It contains multiple cysteine residues forming eight disulfide bonds, which are characteristic of the family[3][8].

Molecular Function

• Ion Channel Regulation: The C-terminal domain is implicated in ion channel regulation, suggesting a role in modulating cellular signaling, especially in reproductive tissues[3][8].
• Innate Immunity: CRISP3 is involved in the innate immune system, with functional associations to immune response pathways[2][3].
• Protease Inhibition: Some studies suggest CRISP family proteins may act as protease inhibitors, though direct evidence for CRISP3 is limited[8].

Biological Processes

• Reproductive Function: Expressed in the male reproductive tract (testis, epididymis, prostate, seminal vesicle), CRISP3 is involved in sperm function and fertilization. In the female reproductive tract (vagina, cervix, endometrium, fallopian tube, ovary), it contributes to endometrial receptivity for embryo implantation[1][3][6][7].
• Immune Defense: CRISP3 is present in neutrophil granules and saliva, indicating a role in host defense mechanisms[8].
• Cancer Biology: Upregulation of CRISP3 is observed in prostate cancer, suggesting a role in tumorigenesis or cancer progression[3][4].

Cellular Localization

• Secreted Protein: CRISP3 is primarily secreted into extracellular fluids, including seminal plasma, saliva, and neutrophil granules[1][8].
• Tissue Distribution: High expression in reproductive tissues, salivary glands, and immune cells. Detected in various organs, including the brain, liver, kidney, and others, but with lower abundance[1][8].

Protein Domains

• Disulfide Bonds: Eight disulfide bonds stabilize the protein structure[3][8].

Known Interactions

• Protein-Protein Interactions: CRISP3 interacts with other CRISP family members (e.g., CRISP2), and may interact with ion channels and immune system proteins, though specific partners are not fully characterized[2][3][8].
• Functional Associations: Over 5,700 functional associations with biological entities, including molecular profiles, pathways, and disease phenotypes[2].

Disease Associations

• Prostate Cancer: CRISP3 is upregulated in prostate cancer tissues and may serve as a biomarker for diagnosis or prognosis[3][4].
• Otitis Media: Some genetic studies link CRISP3 to susceptibility for otitis media (middle ear infection)[3].
• Other Conditions: No strong evidence for direct involvement in other diseases, but its role in immunity and reproduction suggests possible relevance in related disorders[3][6].

Recent Developments (2023–2024)

• Cancer Biomarker Research: Ongoing studies are evaluating CRISP3 as a diagnostic and prognostic marker in prostate cancer, with some evidence supporting its utility in distinguishing aggressive forms[4].
• Functional Genomics: High-throughput association studies continue to map CRISP3’s interactions and regulatory networks, expanding understanding of its role in immunity and reproduction[2].

Expert Opinions and Analysis

• Clinical Relevance: Experts highlight CRISP3’s potential as a non-invasive biomarker for prostate cancer due to its secreted nature and upregulation in malignancy[4].
• Biological Significance: The protein’s dual role in reproduction and immunity is considered unique, with ongoing research into its mechanistic functions and therapeutic potential[3][8].

Relevant Statistics and Data

• Expression: CRISP3 is highly expressed in reproductive tissues and immune cells, with lower levels in other organs[1][8].
• Functional Associations: Over 5,700 associations mapped in computational biology databases[2].
• Disease Prevalence: Prostate cancer is a leading cancer in men; CRISP3 upregulation is observed in a significant subset of cases[4].

Key Sources

• Human Protein Atlas, 2024 (Expression, localization)[1]
• GeneCards, 2024 (Gene summary, domains, disease)[3]
• UniProt, 2024 (Protein structure, domains)[8]
• Wiley, 2023 (Cancer association)[4]
• Ma’ayan Lab Harmonizome, 2024 (Functional associations)[2]

Publication dates and URLs are included above for further reference.

Citations

1. https://www.proteinatlas.org/ENSG00000096006-CRISP3
2. https://maayanlab.cloud/Harmonizome/gene/CRISP3
3. https://www.genecards.org/cgi-bin/carddisp.pl?gene=CRISP3
4. https://onlinelibrary.wiley.com/doi/full/10.2164/jandrol.04132
5. https://en.wikipedia.org/wiki/CRISP3
6. https://www.ncbi.nlm.nih.gov/gene/10321
7. https://www.alliancegenome.org/gene/HGNC:16904
8. https://www.uniprot.org/uniprotkb/P54108/entry